SEI Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Sell
106,390
-47,740
-31% -$1.14M ﹤0.01% 1928
2025
Q4
$4.12M Buy
154,130
+56,100
+57% +$1.34M ﹤0.01% 1466
2025
Q3
$2.09M Buy
98,030
+7,123
+8% +$168K ﹤0.01% 1681
2025
Q2
$1.96M Buy
90,907
+23,068
+34% +$429K ﹤0.01% 1660
2025
Q1
$1.13M Buy
67,839
+17,409
+35% +$316K ﹤0.01% 1860
2024
Q4
$925K Buy
50,430
+18,399
+57% +$297K ﹤0.01% 1977
2024
Q3
$493K Sell
32,031
-703
-2% -$11.7K ﹤0.01% 2188
2024
Q2
$532K Sell
32,734
-2,018
-6% -$32.6K ﹤0.01% 2134
2024
Q1
$642K Buy
34,752
+2,034
+6% +$50.4K ﹤0.01% 2035
2023
Q4
$1.02M Sell
32,718
-19,473
-37% -$465K ﹤0.01% 1872
2023
Q3
$1.09M Buy
52,191
+25,224
+94% +$685K ﹤0.01% 1855
2023
Q2
$646K Buy
26,967
+2,541
+10% +$56.5K ﹤0.01% 2042
2023
Q1
$460K Buy
24,426
+5,093
+26% +$97K ﹤0.01% 2160
2022
Q4
$308K Buy
19,333
+6,656
+53% +$104K ﹤0.01% 2183
2022
Q3
$207K Sell
12,677
-477
-4% -$7.72K ﹤0.01% 2438
2022
Q2
$179K Sell
13,154
-115,453
-90% -$2.15M ﹤0.01% 2488
2022
Q1
$3.12M Sell
128,607
-24,272
-16% -$587K 0.01% 1347
2021
Q4
$3.57M Sell
152,879
-1,422
-0.9% -$28.6K 0.01% 1316
2021
Q3
$2.56M Sell
154,301
-2,712
-2% -$52.3K 0.01% 1407
2021
Q2
$3.83M Sell
157,013
-7,779
-5% -$176K 0.01% 1218
2021
Q1
$4.67M Buy
164,792
+57,095
+53% +$2.51M 0.01% 1055
2020
Q4
$5.73M Buy
107,697
+25,096
+30% +$1.25M 0.01% 915
2020
Q3
$3.4M Sell
82,601
-18,154
-18% -$784K 0.01% 1050
2020
Q2
$4.88M Sell
100,755
-8,707
-8% -$418K 0.02% 868
2020
Q1
$4.63M Buy
109,462
+7,730
+8% +$319K 0.02% 795
2019
Q4
$4.35M Sell
101,732
-2,568
-2% -$112K 0.01% 983
2019
Q3
$3.75M Buy
104,300
+18,040
+21% +$547K 0.01% 1048
2019
Q2
$2.31M Buy
86,260
+10,711
+14% +$274K 0.01% 1270
2019
Q1
$2.03M Buy
75,549
+71,168
+1,624% +$1.66M 0.01% 1301
2018
Q4
$91K Sell
4,381
-10,450
-70% -$203K ﹤0.01% 2218
2018
Q3
$316K Sell
14,831
-35,276
-70% -$555K ﹤0.01% 1785
2018
Q2
$766K Buy
50,107
+49,170
+5,248% +$877K ﹤0.01% 1691
2018
Q1
$21K Sell
937
-21,224
-96% -$588K ﹤0.01% 2631
2017
Q4
$667K Buy
22,161
+2,590
+13% +$82.8K ﹤0.01% 1599
2017
Q3
$737K Buy
19,571
+2,565
+15% +$83.4K ﹤0.01% 1535
2017
Q2
$475K Sell
17,006
-9,831
-37% -$293K ﹤0.01% 1642
2017
Q1
$923K Buy
26,837
+15,755
+142% +$556K ﹤0.01% 1410
2016
Q4
$320K Sell
11,082
-67,658
-86% -$1.79M ﹤0.01% 1680
2016
Q3
$2.5M Buy
78,740
+22,663
+40% +$768K 0.01% 1003
2016
Q2
$1.82M Buy
56,077
+26,000
+86% +$870K 0.01% 1023
2016
Q1
$841K Sell
30,077
-4,737
-14% -$103K 0.01% 1179
2015
Q4
$1.24M Sell
34,814
-29,722
-46% -$1.05M 0.01% 1155
2015
Q3
$2.13M Buy
64,536
+36,965
+134% +$1.54M 0.02% 775
2015
Q2
$1.16M Sell
27,571
-1,795
-6% -$69.5K 0.01% 937
2015
Q1
$957K Sell
29,366
-7,142
-20% -$245K 0.01% 989
2014
Q4
$1.16M Buy
+36,508
New +$1.04M 0.01% 897

Other funds holding ACAD